Topiramate augmentation in patients with resistant major depressive disorder: A double-blind placebo-controlled clinical trial
Authors:
- Arash MowlaAMArash Mowla
- Ehsan KardehEKEhsan Kardeh
- 1 June 2011
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 35 (4) , 970-973
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD)Journal of Mental Health, 2010
- Anticonvulsants in the Treatment of Major Depressive DisorderHarvard Review of Psychiatry, 2009
- Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trialsThe British Journal of Psychiatry, 2009
- Current trends in the assessment and somatic treatment of resistant/refractory major depression: An overviewAnnals of Medicine, 2008
- Navigating the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) Study: Practical Outcomes and Implications for Depression Treatment in Primary CarePrimary Care: Clinics in Office Practice, 2007
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLOS Medicine, 2006
- Subunit selectivity of topiramate modulation of heteromeric GABAA receptorsNeuropharmacology, 2006
- Epidemiology of Major Depressive DisorderArchives of General Psychiatry, 2005
- Topiramate in treatment of depressive and anger symptoms in female depressive patients: A randomized, double-blind, placebo-controlled studyJournal of Affective Disorders, 2005
- Potentiation of Antidepressants with Lithium or Carbamazepine in Treatment-Resistant DepressionNeuropsychobiology, 1999